Precigen (PGEN) Other Non-Current Liabilities (2012 - 2026)
Precigen's (PGEN) quarterly Other Non-Current Liabilities came in at $106000.0 in Q1 2026, down 99.87% year-on-year from $83.0 million in Q1 2025, and down 20.9% on a QoQ basis from $134000.0 in Q4 2025.
Precigen (PGEN) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 13 years of Other Non-Current Liabilities data on file, last reported at $106000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities fell 99.87% year-over-year to $106000.0 in Q1 2026; TTM through Mar 2026 was $106000.0, a 99.87% decrease from a year earlier, with the FY2025 full-year figure at $134000.0, changed N/A from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $106000.0, down from $134000.0 in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for PGEN reached as high as $83.0 million in Q1 2025 and fell as low as $50000.0 in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $32.4 million across 3 years, with a median of $134000.0 in 2025.
- Across the five-year window, Other Non-Current Liabilities slumped 50.0% in 2022 and plunged 99.87% in 2026, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $50000.0 in 2022, then surged by 168.0% to $134000.0 in 2025, then fell by 20.9% to $106000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $106000.0 in Q1 2026, $134000.0 in Q4 2025, and $78.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106,000.00 |
| Dec 31, 2025 | 134,000.00 |
| Jun 30, 2025 | 78.56 Mn |
| Mar 31, 2025 | 83.02 Mn |
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Sep 30, 2021 | 50,000.00 |
| Jun 30, 2021 | 50,000.00 |
| Mar 31, 2021 | 100,000.00 |
| Dec 31, 2020 | 100,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 100,000.00 |
| Sep 30, 2019 | 221,000.00 |
| Jun 30, 2019 | 222,000.00 |
| Mar 31, 2019 | 662,000.00 |
| Dec 31, 2018 | 3.14 Mn |
| Sep 30, 2018 | 3.20 Mn |
| Jun 30, 2018 | 3.17 Mn |
| Mar 31, 2018 | 3.59 Mn |
| Dec 31, 2017 | 3.45 Mn |